Repros Therapeutics Inc.
Records under this name other than patents Repros Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Repros Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,519,004 | Dosing regimes for trans-clomiphene Formerly held Lapsed on the fee record Ended Aug 27, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 27, 2025 | USPTO record |
| US 9,687,458 | Trans-clomiphene for use in cancer therapy Lapsed on the fee record Ended Jun 27, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2025 | USPTO record |
| US 8,426,394 | Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc Formerly held Lapsed on the fee record Ended Apr 23, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | USPTO record |
| US 9,616,034 | Trans-clomiphene and its analogues as agents that increase bone mineral density Lapsed on the fee record Ended Apr 11, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 11, 2025 | USPTO record |
| US 9,616,074 | Compositions and methods for suppressing endometrial proliferation Formerly held Lapsed on the fee record Ended Apr 11, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 11, 2025 | USPTO record |
| US 8,377,991 | Trans-clomiphene for metabolic syndrome Lapsed on the fee record Ended Feb 19, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 19, 2025 | USPTO record |
| US 8,372,887 | Trans-clomiphene for metabolic syndrome Lapsed on the fee record Ended Feb 12, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 12, 2025 | USPTO record |
| US 9,545,411 | Methods and compositions for treating progesterone-dependent conditions Formerly held Lapsed on the fee record Ended Jan 17, 2025 · USPTO record | Lapsed on the fee record | Ended Jan 17, 2025 | USPTO record |
| US 8,247,456 | Dosing regimes for trans-clomiphene Formerly held Lapsed on the fee record Ended Aug 21, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 21, 2024 | USPTO record |
| US 9,283,234 | Compositions and methods for suppressing endometrial proliferation Formerly held Lapsed on the fee record Ended Mar 15, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2024 | USPTO record |